Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Corrigendum: Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

Bibliographic Details
Main Authors:	Qi Chang Zheng, Shuai Jiang, Yu Zhe Wu, Dan Shang, Yong Zhang, Shao Bo Hu, Xiang Cheng, Chen Zhang, Ping Sun, Yang Gao, Zi Fang Song, Min Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Bioengineering and Biotechnology
Subjects:	small interfering RNA gene therapy targeted therapy chitosan hepatocellular carcinoma drug delivery
Online Access:	https://www.frontiersin.org/articles/10.3389/fbioe.2021.656268/full

Similar Items

Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
by: Qi Chang Zheng, et al.
Published: (2020-06-01)

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
by: Li M, et al.
Published: (2016-10-01)

Coupling Aptamers to Short Interfering RNAs as Therapeutics
by: Vittorio de Franciscis, et al.
Published: (2011-10-01)

Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro
by: Zhuo Wu, et al.
Published: (2017-05-01)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
by: Ziyu Liu, et al.
Published: (2019-11-01)

Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
by: Xuejun Ai, et al.
Published: (2018-11-01)

Immunotherapy and targeted therapy converted radical surgery in an advanced hepatocellular carcinoma with tumor emboi of portal vein and hepatic vein
by: Xing-Hua Huang, et al.
Published: (2021-10-01)

Evaluation the Efficacy of Granulated Metallic-Magnetic Chitosan Nanocomposite for Adsorption of Interfering Anions in Aqueous Solutions
by: Zahra Farajollahi, et al.
Published: (2019-12-01)

Advances in locoregional therapy for hepatocellular carcinoma combined with immunotherapy and targeted therapy
by: Jian Xue, et al.
Published: (2021-08-01)

Molecular targeted therapy for hepatocellular carcinoma
by: SHEN Yinan
Published: (2015-01-01)

Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer
by: Ga Hee Kim, et al.
Published: (2018-01-01)

Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
by: Beate Schultheis, et al.
Published: (2020-10-01)

Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma
by: Manali Dimri, et al.
Published: (2020-02-01)

Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy
by: Khanh Nguyen, et al.
Published: (2015-12-01)

Safety and Clinical Efficacy of PD-1 on Advanced Primary Hepatocellular Carcinoma
by: WANG Yixin, et al.
Published: (2020-04-01)

Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
by: Masatoshi Kudo
Published: (2018-10-01)

Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
by: Park R, et al.
Published: (2021-03-01)

The Advances and Challenges in Utilizing Exosomes for Delivering Cancer Therapeutics
by: Mengliu Yang, et al.
Published: (2018-07-01)

STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma
by: Carol Lee, et al.
Published: (2019-10-01)

Cloned Defective Interfering Influenza RNA and a Possible Pan-Specific Treatment of Respiratory Virus Diseases
by: Nigel J. Dimmock, et al.
Published: (2015-07-01)

Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
by: Kaseb AO, et al.
Published: (2016-02-01)

The Antiviral and Antitumor Effects of Defective Interfering Particles/Genomes and Their Mechanisms
by: Yicheng Yang, et al.
Published: (2019-08-01)

Emerging agents and regimens for hepatocellular carcinoma
by: Xiao-Dong Zhu, et al.
Published: (2019-10-01)

Clinical cases of treatment of hepatocellular carcinoma
by: S A Lazarev, et al.
Published: (2014-03-01)

Potential of novel colchicine dosage schedule for the palliative treatment of advanced hepatocellular carcinoma
by: Zu‐Yau Lin, et al.
Published: (2021-07-01)

The role of long noncoding RNAs in hepatocellular carcinoma
by: Zhao Huang, et al.
Published: (2020-04-01)

Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies
by: Ali Alqahtani, et al.
Published: (2019-08-01)

A54 peptide-mediated functionalized gold nanocages for targeted delivery of DOX as a combinational photothermal-chemotherapy for liver cancer
by: Huang S, et al.
Published: (2017-07-01)

siRNA Delivery Technology for Cancer Therapy: Promise and Challenges
by: Fateme Karimi Dermani, et al.
Published: (2019-03-01)

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
by: Francesca Matilde Schipilliti, et al.
Published: (2021-01-01)

Glypican-3-Targeted Alpha Particle Therapy for Hepatocellular Carcinoma
by: Meghan M. Bell, et al.
Published: (2021-12-01)

Nanoparticle-based strategy for personalized B-cell lymphoma therapy
by: Martucci NM, et al.
Published: (2016-11-01)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
by: L. V. Bolotina
Published: (2020-11-01)

Immunostimulatory function of the defective interfering RNA of Sendai virus
by: Ho, Ting-hin, et al.
Published: (2014)

Modulation of the TGF-β signaling pathway by long noncoding RNA in hepatocellular carcinoma
by: Mengzhen Han, et al.
Published: (2020-12-01)

Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma: A Literature Review and Treatment Perspectives
by: Daniel M. Girardi, et al.
Published: (2021-12-01)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
by: Hyuk Moon, et al.
Published: (2021-06-01)

In vitro and in vivo evaluation of self-assembled chitosan nanoparticles selectively overcoming hepatocellular carcinoma via asialoglycoprotein receptor
by: Rensong Sun, et al.
Published: (2021-01-01)

Insights into the therapeutic potential of hypoxia-inducible factor-1α small interfering RNA in malignant melanoma delivered via folate-decorated cationic liposomes
by: Chen Z, et al.
Published: (2016-03-01)

Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
by: Koulouris A, et al.
Published: (2021-05-01)